These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21391003)

  • 1. Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
    Li X; Wang WW; Liu GF; Chan IS
    J Biopharm Stat; 2011 Mar; 21(2):294-310. PubMed ID: 21391003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
    Wei L
    J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical considerations for noninferiority/equivalence trials in vaccine development.
    Wang WW; Mehrotra DV; Chan IS; Heyse JF
    J Biopharm Stat; 2006; 16(4):429-41. PubMed ID: 16892905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missing data in confirmatory clinical trials.
    Flyer P; Hirman J
    J Biopharm Stat; 2009 Nov; 19(6):969-79. PubMed ID: 20183459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missing data in the regulation of medical devices.
    Campbell G; Pennello G; Yue L
    J Biopharm Stat; 2011 Mar; 21(2):180-95. PubMed ID: 21390995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing data handling methods in medical device clinical trials.
    Yan X; Lee S; Li N
    J Biopharm Stat; 2009 Nov; 19(6):1085-98. PubMed ID: 20183466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling missing data issues in clinical trials for rheumatic diseases.
    Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE
    Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the treatment effect in clinical trials with dropout.
    Shao J; Zhong B
    J Biopharm Stat; 2006; 16(1):25-33. PubMed ID: 16440835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
    Kong L; Kohberger RC; Koch GG
    J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
    Ali MW; Siddiqui O
    J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation.
    Plikaytis BD; Carlone GM
    Vaccine; 2005 Feb; 23(13):1606-14. PubMed ID: 15694513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missing data issues at the FDA Center for Biologics Evaluation and Research.
    Scott JA; Hsu H
    J Biopharm Stat; 2011 Mar; 21(2):196-201. PubMed ID: 21390996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.